Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.
Epistemonikos ID: 582d0a6121bc2f3e69ab2f94622acc5049a5de91
First added on: May 04, 2024